Monoclonal Antibody Therapy to Treat COVID-19

Monoclonal antibody therapy is a life-saving treatment used for COVID-19 and is administered via IV infusion.

 

For use in adults and pediatric patients (12 years and older)
Covid-19 patient
For high-risk patients who have been exposed to COVID-19, monoclonal antibody therapy can reduce the risk of severe disease, hospitalization, and death by 70%, and decreases your odds of infection by over 80% – or if you are infected, reduce the length of COVID-19 symptoms by four days, on average. Direct access to early treatment is essential to saving lives.

DO YOU NEED TESTING, VACCINATION, OR MONOCLONAL ANTIBODY TREATMENT SERVICES?

Bebtelovimab is an FDA authorized monoclonal antibody therapy used for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg):

With positive results of direct SARS-CoV-2 viral testing, and

Who are at high risk for progression to severe COVID-19, including hospitalization or death, and

For whom alternative COVID-19 treatment options approved or authorized by FDA are not accessible or clinically appropriate

TREATMENT – WHAT TO EXPECT

Bebtelovimab is administered via IV. Patient will be observed for 1 hour after administration.

INTERESTED IN LEARNING ABOUT COVID-19 PREVENTATIVE TREATMENT?

BENEFITS OF RECEIVING MONOCLONAL ANTIBODY TREATMENT IN OUR CLINIC

Ability to schedule an appointment and avoid long wait-times

Receive quality care by industry leaders in pandemic response

Receive treatment in private, at our state-of-the-art facility

Easily schedule a Telehealth session to follow-up on treatment and recovery

MAB THERAPY

$450.00

How to retrieve Proof of treatment via Patient Portal

 

If you already received the treatment in our clinic, and need to obtain proof of it, follow the instructions below.
OPEN STEP BY STEP INSTRUCTIONS

WANT TO LEARN MORE ABOUT TESTING, VACCINATIONS OR TELEHEALTH SERVICES?